A Game-based Neurodevelopmental Assessment for Young Children

Launched by BRIGHTLOBE LIMITED · Mar 10, 2023

Keywords

ClinConnect Summary

This clinical trial is studying a new game on a tablet designed to assess the development of young children aged 3 to 8 years old. The goal is to see if this fun, interactive game can accurately measure how well children are doing in areas like attention, memory, language, and social skills. Researchers want to find out if this game can help identify children who may have neurodevelopmental disorders, such as Autism Spectrum Disorder, Attention Deficit Hyperactivity Disorder (ADHD), or learning difficulties.

To participate, children must be between 3 and 8 years old and either developing typically or diagnosed with a neurodevelopmental disorder. Parents or caregivers will complete a questionnaire to provide more information about the child's development. Each child will play the tablet game, and some may play it again after two weeks to ensure the results are consistent. This study aims to recruit 590 children, and it’s important that all participants can understand and communicate in English. If you’re considering this opportunity for your child, know that it’s a chance to help researchers learn more about how to support children’s development in engaging ways.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 3 to 8 year old 'typically' developing children with no known neurodevelopmental disorder.
• • OR
• • 3 to 8 year old children with a diagnosed neurodevelopmental disorder, including Attention Deficit Hyperactivity Disorder (ADHD), Autism Spectrum Disorder (ASD), Specific Learning Disorder, or a Communication Disorder.
• • All parents/caregivers and children must have a minimum level of English fluency required to complete the parent questionnaire and the game-based assessment.
• Exclusion Criteria:
• • Children with medical comorbidities, a chronic illness or any additional diagnoses that would impact their ability to complete the game-based assessment.